Fig. 3.

Cumulative incidence of advanced fibrosis according to the presence of risk factors (based on 150 liver biopsies).

Risk factors considered for analysis: Pre-LT metabolic syndrome, grade ≥2 steatosis at 1 year after LT and long-term use of cyclosporine. In the group with risk factors, incidence of advanced fibrosis was 5.3% at 1 year after LT, 58.3% at 5 years and 77.7% at 10 years. In the group without risk factors, incidence of advanced fibrosis was 0.0% at 1 year, 5.3% at 5 years and 48.4% at 10 years after LT. The difference is significant between the two groups of patients (p = 0.001). Kaplan-Meier analysis. LT, liver transplantation.